Journavx is the first truly new painkiller approved by the Food and Drug Administration in more than 20 years. But the drug is expensive, and many people can't get it yet.

Diabetic neuropathy pain can be effectively managed through a combination of medical treatment, lifestyle changes, and supportive therapies ...

Naturally reducing HbA1c involves a change of lifestyle, based on conscious eating, constant exercise, emotional balance, and ...

Geneva: The World Health Organization (WHO) has issued a global safety alert highlighting the risk of non-arteritic anterior ...

NAION risk is most significant within the first 12 months of beginning semaglutide, and is highest in patients with additional risk factors.

Fact checked by Jennifer Klump GLP-1 drugs may increase the risk of a severe form of macular degeneration in older adults with diabetes, according to a recent study published in JAMA Ophthalmology. A ...

June 6 (Reuters) - Novo Nordisk's (NOVOb.CO) popular weight-loss and diabetes drugs Wegovy and Ozempic may in very rare cases cause a serious eye condition that can lead to vision loss, the European ...

Diabetic neuropathy is one of the most common forms of neuropathic pain and affects about 11 million people — nearly one-third of the 38 million diabetics in the United States, according to the ...

Diabetic neuropathy is caused by cardiovascular changes, genetics, and other risk factors. The main cause of diabetic neuropathy is prolonged high blood sugar levels, or hyperglycemia, which can ...

In patients with diabetes, semaglutide use was associated with an increased risk for nonarteritic anterior ischemic optic neuropathy, according to a study published in JAMA Ophthalmology.

Diabetic neuropathy is a complication of type 1 and type 2 diabetes that develops slowly over time. This article takes a closer look at the symptoms, treatment, and causes of diabetic neuropathy.